Isolere Bio

United States
Long Beach, Maryland, United States, 27713

Company profile

Isolere Bio company profile

Isolere Bio is a Healthcare Company.Monoclonal antibodies make up an effective and rapidly growing class of drugs. They are also critical research tools and essential for the development of many new diagnostics. Isolere Bio was co-founded with the vision of simplifying and streamlining the purification of biotherapeutics to improve global access to these important drugs.

Business identity

Contact email
[email protected]
Phone number
719-322-4394
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
27713
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
6
Total equity funding
$7M
Last funding
Grant / $75,000 / 2022-09-22
Last equity funding
Seed / $7M
Investors
4
Lead investors
4
Founders
1
Articles
29
Exited on
2023-02-21

Founders and investors

Founders

Joseph T. McMahon

Lead investors

National Science FoundationNorth Carolina Biotechnology CenterNorthpond VenturesOne North Carolina Small Business Program

Investors

National Science FoundationNorth Carolina Biotechnology CenterNorthpond VenturesOne North Carolina Small Business Program